FASTIN CAP 30MG DIN 01916831
Status: Cancelled Post Market
Holder: SMITHKLINE BEECHAM PHARMA DIVISION OF SMITHKLINE BEECHAM INC
Molecule: PHENTERMINE HYDROCHLORIDE
Health Canada record
| Active ingredient(s) | PHENTERMINE HYDROCHLORIDE 30 MG |
|---|---|
| Dosage form | Capsule |
| Route | Oral |
| Schedule | CONTROLLED DRUGS (CDSA IV) |
| Class | Human |
| ATC | A08AA01 PHENTERMINE |
| Original market date | 31-Dec-1993 |
| Current status date | 02-Feb-1999 |
| Source | Health Canada DPD |
Establishment licence of the holder
Smithkline Beecham Ltd T/A Smithkline Beecham Pharmaceuticals — licence , not currently licensed, last inspection rating C (2024-12-20).
No Canadian shortage report is currently matched to this DIN.
International API supply for PHENTERMINE HYDROCHLORIDE
6 active FDA Drug Master Files.
Request a quote for FASTIN CAP 30MG